Sjors M. Kas

1.0k citations

10 papers · 646 indexed · 1 hit paper · h-index 7

Co-authors: Jos Jonkers Eva Schut Anne Paulien Drenth Lodewyk F.A. Wessels Martine H. van Miltenburg Renske de Korte‐Grimmerink Karin E. de Visser Ingrid van der Heijden
Topics: CRISPR and Genetic Engineering (3 papers)Epigenetics and DNA Methylation (3 papers)Genomics and Chromatin Dynamics (2 papers)
Cited by: Oncology Cancer Research Immunology
Journals: Nature Nucleic Acids Research Nature Genetics
Partner nations: Netherlands United Kingdom Italy

In The Last Decade

Sjors M. Kas

9 papers receiving 641 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

2019 361 citations Max D. Wellenstein, Seth B. Coffelt et al. Nature profile →

Peers

Countries citing papers authored by Sjors M. Kas

Since Specialization

Citations

This map shows the geographic impact of Sjors M. Kas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sjors M. Kas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sjors M. Kas more than expected).

Fields of papers citing papers by Sjors M. Kas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sjors M. Kas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sjors M. Kas. The network helps show where Sjors M. Kas may publish in the future.

Co-authorship network of co-authors of Sjors M. Kas

This figure shows the co-authorship network connecting the top 25 collaborators of Sjors M. Kas. A scholar is included among the top collaborators of Sjors M. Kas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sjors M. Kas. Sjors M. Kas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	HSP90 inhibition reverses resistance to TRAIL-induced apoptosis in non-small cell lung cancer cells 2025 ·SHILAP Revista de lepidopterología ·Kaamar Azijli,Geng Xu,(unknown),(unknown),Shiv Pillai,Sjors M. Kas,Antonio Russo,Elisa Giovannetti,Steven de Jong,Godefridus J. Peters,Frank A.E. Kruyt	0
2	Functional classification of DDOST variants of uncertain clinical significance in congenital disorders of glycosylation 2023 ·Scientific Reports ·Sjors M. Kas,Piyushkumar A. Mundra,Duncan L. Smith,Richard Marais	2
3	Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system 2020 ·OncoImmunology ·Sjoerd Klarenbeek,Chris W. Doornebal,Sjors M. Kas,Nicola Bonzanni,Jinhyuk Bhin,Tanya M. Braumuller,Ingrid van der Heijden,Mark Opdam,Philip C. Schouten,Kelly Kersten,Roebi de Bruijn,Daniel Zingg,(unknown),Lodewyk F.A. Wessels,Karin E. de Visser,Jos Jonkers	8
4	Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasisbreakdown → 2019 ·Nature ·Max D. Wellenstein,Seth B. Coffelt,Danique E. M. Duits,Martine H. van Miltenburg,Maarten Slagter,Iris de Rink,Linda Henneman,Sjors M. Kas,Stefan Preković,Cheei‐Sing Hau,Kim Vrijland,Anne Paulien Drenth,Renske de Korte‐Grimmerink,Eva Schut,Ingrid van der Heijden,Wilbert Zwart,Lodewyk F.A. Wessels,Ton N. Schumacher,Jos Jonkers,Karin E. de Visser	361
5	Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547 2018 ·Cancer Research ·Sjors M. Kas,Julian R. de Ruiter,Koen Schipper,Eva Schut,Lorenzo Bombardelli,Ellen Wientjens,Anne Paulien Drenth,Renske de Korte‐Grimmerink,Sunny Mahakena,Christopher Phillips,Paul Smith,Sjoerd Klarenbeek,Koen van de Wetering,Anton Berns,Lodewyk F.A. Wessels,Jos Jonkers	30
6	Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma 2017 ·Nature Genetics ·Sjors M. Kas,Julian R. de Ruiter,Koen Schipper,Stefano Annunziato,Eva Schut,Sjoerd Klarenbeek,Anne Paulien Drenth,Eline van der Burg,Christiaan Klijn,Jelle J. ten Hoeve,David J. Adams,Marco J. Koudijs,Jelle Wesseling,Micha Nethe,Lodewyk F.A. Wessels,Jos Jonkers	55
7	Identifying transposon insertions and their effects from RNA-sequencing data 2017 ·Nucleic Acids Research ·Julian R. de Ruiter,Sjors M. Kas,Eva Schut,David J. Adams,Marco J. Koudijs,Lodewyk F.A. Wessels,Jos Jonkers	6
8	Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland 2016 ·Genes & Development ·Stefano Annunziato,Sjors M. Kas,Micha Nethe,Hatice Yücel,(unknown),Colin E.J. Pritchard,Rahmen Bin Ali,(unknown),Bjørn Siteur,Anne Paulien Drenth,Eva Schut,Marieke van de Ven,Mirjam C. Boelens,Sjoerd Klarenbeek,Ivo J. Huijbers,Martine H. van Miltenburg,Jos Jonkers	100
9	High-throughput semiquantitative analysis of insertional mutations in heterogeneous tumors 2011 ·Genome Research ·Marco J. Koudijs,Christiaan Klijn,(unknown),Jaap Kool,Jelle ten Hoeve,Daoud Sie,Pramudita R. Prasetyanti,Eva Schut,Sjors M. Kas,(unknown),Edwin Cuppen,Lodewyk F.A. Wessels,David J. Adams,Jos Jonkers	32
10	Fusicoccin-A selectively induces apoptosis in tumor cells after interferon-α priming 2010 ·Cancer Letters ·(unknown),(unknown),(unknown),Sjors M. Kas,Antonio Evidente,Albertus H. de Boer	52

About Sjors M. Kas

Sjors M. Kas is a scholar working on Molecular Biology, Immunology and Dermatology, having authored 10 papers that have together received 646 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (3 papers), Epigenetics and DNA Methylation (3 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Oncology (258 citations), Cancer Research (131 citations) and Immunology (164 citations). Sjors M. Kas has collaborated with scholars based in Netherlands, United Kingdom and Italy. Frequent co-authors include Jos Jonkers, Eva Schut, Anne Paulien Drenth, Lodewyk F.A. Wessels, Martine H. van Miltenburg, Renske de Korte‐Grimmerink, Karin E. de Visser, Ingrid van der Heijden, Ton N. Schumacher and Linda Henneman. Their work appears in journals such as Nature, Nucleic Acids Research and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact